Launching a venture? Here’s advice from MIT entrepreneurs in residence on navigating artificial intelligence, the economy, and uncertainty.
The new arrivals are experts in data privacy, global economics, management, and consumer attention.
A Chilean experiment with legal aid and social services cuts time in foster care, with lasting effects for kids and lower costs for programs.
A new book from an MIT Sloan School of Management professor explores how we balance doing what’s right with doing what works — and what we’re really willing to give up for our values.
Companies that adopt industrial artificial intelligence see productivity losses before longer-term gains, according to new research.
Researchers propose new royalty-based investment model to bridge the ‘valley of death’ and accelerate drug development.
Artificial intelligence improves efficiency in risk management and compliance, but humans are still best for customer-facing tasks, a new study finds.
Enterprises racing to adopt AI must be wary of giving into hype, downplaying ethical concerns, and focusing on use cases that won’t generate real value.
The startup’s device could expand access, reduce cost, and reduce injection time for biologic drugs for cancer and autoimmune diseases.
From assessing bridge infrastructure to predicting worker fatigue risk via voice analysis, these startups are widening the scope of what artificial intelligence can do.
